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According to a 2005 study done by the American Cancer Society, prostate 
cancer is the second most common type of cancer among American men. It has 
been shown that estrogen receptors alpha and beta play significant roles in 
the development and inhibition of prostate cancer. To further understand the 
roles ERs play in prostate cancer, a Transgenic Adenocarcinogenic of the 
Mouse Prostate (TRAMP) model was utilized. Simply put, these DNA engineered 
mice are highly likely to develop a prostate cancer similar to the type 
experienced by humans. Similar to humans, in TRAMP mice there are different 
stages of prostate cancer; well differentiated carcinoma (WDC) and poorly 
differentiated carcinoma (PDC) are the stages being we study extensively. It 
has been shown that double transgenic ER alpha knockout/ TRAMP mice have 
decreased incidence of PDC, while ER beta knockout/ TRAMP mice have increased 
incidence of PDC, which implies different roles for ER α and ER β in prostate 
cancer. The TRAMP C2 cell line is derived from TRAMP mice and potentially 
serve as a good model for in vitro studies of prostate cancer. This cell line 
would be useful for studying estrogen effects on prostate cancer, if it 
contained ER α and β. Our hypothesis is that TRAMP C2 cells are ER α and ER β 
positive. The goal of this research is to test for the presence of these 
proteins in the TRAMP C2 cell line. To test for the presence of ER alpha and 
ER beta, the Western blot method was used. Western Blot is a widely accepted 
and efficient method for detecting a specific protein among a mixture of many 
different ones. In conclusion, both estrogen receptor α and β are present in 
TRAMP C2 cells. With this confirmation, the cure to prostate cancer is one 
step closer because this TRAMP C2 cell line will be well suited for 
determining the benefits of ER alpha and ER beta manipulation. 
